'Chemobrain' Linked to Changes in Brain Activity While Multitasking

Share this content:

the Cancer Therapy Advisor take:

Cognitive complaints among patients with cancer undergoing chemotherapy are not uncommon, which has prompted research into the phenomenon known as "chemobrain." In this recent study published in the Journal of Clinical Oncology, researchers employed functional magnetic resonance imaging (MRI) to compare women with breast cancer with themselves before and after chemotherapy as well as with other women. Results revealed a decrease in brain activation while performing a multitasking exercise among the women with breast cancer who had undergone chemotherapy, as compared with healthy women and women with breast cancer who had not undergone chemotherapy. Further studies, however, are needed to address cognitive risks while effectively treating cancer, according to the researchers.

Successful First Step for Vaccine Targeting Brain Cancer Mutation
Successful First Step for Vaccine Targeting Brain Cancer Mutation
For some women with breast cancer, changes in brain activity while multitasking could explain "chemo brain" --- reduced mental functioning that many experience after chemotherapy, Belgian researchers say. "Cognitive complaints of people increase with chemotherapy and we are trying to find out why," said Sabine Deprez, who led the new study.
READ FULL ARTICLE From Chicago Tribune

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs